Literature DB >> 32399728

Natural history of incidentally diagnosed brainstem cavernous malformations in a prospective observational cohort.

Jing-Jie Zheng1, Pan-Pan Liu2,3, Liang Wang2, Li-Wei Zhang2, Jun-Ting Zhang2, Da Li4, Zhen Wu5, Yu-Mei Wu6.   

Abstract

There was a lack of natural history of incidental brainstem cavernous malformations (CMs), hemorrhage of which would lead to severe neuropathies. The study aimed to evaluate the prospective hemorrhage rate and neurological outcome of the disease. This prospective cohort included patients with incidental brainstem CMs referred to our institute from 2009 to 2015. The diagnosis was confirmed based on the patients' complain, physical examination, and radiographic evidence. Clinical data were collected, scheduled follow-up was performed, and the independent risk factors were identified by multivariate analysis. This cohort included 48 patients (22 female, 45.8%). The median follow-up duration was 60.7 months, and 13 prospective hemorrhages occurred within 244.0 patient-years yielding an annual hemorrhage rate of 5.3%. The hemorrhage-free survival at 1 and 5 years was 91.6% and 80.6%. Age ≥ 55 years (hazard ratio (HR) = 8.59, p = 0.003), lesion size (per 1-mm increase) (HR = 3.55, p = 0.041), developmental venous anomaly (HR = 10.28, p = 0.017), and perilesional edema (HR = 4.90, p = 0.043) were independent risk factors for hemorrhage. Seven patients (14.6%) received surgical resection, and the other 41 patients remained under observation. Neurological function was improved in 22 patients (45.8%), unchanged in 19 (39.6%), and worsened in 7 (14.6%). Prospective hemorrhage (odds ratio = 14.95, p = 0.037) was the only independent risk factor for worsened outcomes. The natural history of incidental brainstem CMs seemed to be acceptable with improved/unchanged outcomes in most patients (85.4%). These results improved our understanding of the disease, and the future study of a large cohort was required to verify our findings.

Entities:  

Keywords:  Brainstem cavernous malformations; Cavernoma; Cavernous angioma; Cerebral cavernous malformations; Natural history

Year:  2020        PMID: 32399728     DOI: 10.1007/s10143-020-01308-0

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  41 in total

1.  Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system.

Authors:  F G Barker; S Amin-Hanjani; W E Butler; S Lyons; R G Ojemann; P H Chapman; C S Ogilvy
Journal:  Neurosurgery       Date:  2001-07       Impact factor: 4.654

Review 2.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

3.  Advances in the treatment and outcome of brainstem cavernous malformation surgery: a single-center case series of 300 surgically treated patients.

Authors:  Adib A Abla; Gregory P Lekovic; Jay D Turner; Jean G de Oliveira; Randall Porter; Robert F Spetzler
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

4.  Natural history and imaging prevalence of cavernous malformations in children and young adults.

Authors:  Wajd N Al-Holou; Thomas M O'Lynnger; Aditya S Pandey; Joseph J Gemmete; B Gregory Thompson; Karin M Muraszko; Hugh J L Garton; Cormac O Maher
Journal:  J Neurosurg Pediatr       Date:  2012-02       Impact factor: 2.375

5.  Predictive factors for intracerebral hemorrhage in patients with cavernous angiomas.

Authors:  Carlos Cantu; Luis Murillo-Bonilla; Antonio Arauz; Jesús Higuera; Joel Padilla; Fernando Barinagarrementeria
Journal:  Neurol Res       Date:  2005-04       Impact factor: 2.448

6.  Cavernous malformations of the brainstem presenting in childhood: surgical experience in 40 patients.

Authors:  Adib A Abla; Gregory P Lekovic; Mark Garrett; David A Wilson; Peter Nakaji; Ruth Bristol; Robert F Spetzler
Journal:  Neurosurgery       Date:  2010-12       Impact factor: 4.654

Review 7.  Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board.

Authors:  Rustam Al-Shahi Salman; Michel J Berg; Leslie Morrison; Issam A Awad
Journal:  Stroke       Date:  2008-10-30       Impact factor: 7.914

8.  Natural history of intracranial cavernous malformations.

Authors:  T Aiba; R Tanaka; T Koike; S Kameyama; N Takeda; T Komata
Journal:  J Neurosurg       Date:  1995-07       Impact factor: 5.115

9.  Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.

Authors:  Rustam Al-Shahi Salman; Julie M Hall; Margaret A Horne; Fiona Moultrie; Colin B Josephson; Jo J Bhattacharya; Carl E Counsell; Gordon D Murray; Vakis Papanastassiou; Vaughn Ritchie; Richard C Roberts; Robin J Sellar; Charles P Warlow
Journal:  Lancet Neurol       Date:  2012-01-31       Impact factor: 44.182

Review 10.  Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel.

Authors:  Amy Akers; Rustam Al-Shahi Salman; Issam A Awad; Kristen Dahlem; Kelly Flemming; Blaine Hart; Helen Kim; Ignacio Jusue-Torres; Douglas Kondziolka; Cornelia Lee; Leslie Morrison; Daniele Rigamonti; Tania Rebeiz; Elisabeth Tournier-Lasserve; Darrel Waggoner; Kevin Whitehead
Journal:  Neurosurgery       Date:  2017-05-01       Impact factor: 4.654

View more
  1 in total

1.  Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort.

Authors:  Lu Kong; Xiu-Jian Ma; Xiao-Ying Xu; Pan-Pan Liu; Ze-Yu Wu; Li-Wei Zhang; Jun-Ting Zhang; Zhen Wu; Liang Wang; Da Li
Journal:  Neurosurg Rev       Date:  2022-05-28       Impact factor: 2.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.